Patrick Burnett, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 1,697 shares at $27.00 ($46K) on 2026-08-19, disclosed to the SEC on 2026-08-21.
Seasonal sale ($46k) by See Remarks — this insider has traded ARQT in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ARQT | SELL | 2026-05-13 | $5K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $16K | — | Filing → |
| ARQT | SELL | 2026-03-03 | $317K | — | Filing → |